Rose-Nussbaumer, MD; for the Mycotic Ulcer Treatment Trial Group IMPORTANCE Identifying patients with infectious keratitis who are at risk of experiencing a poor outcome may be useful to allocate resources toward high-risk patients, particularly in resource-poor settings.
C orneal perforation is a common complication of severe fungal keratitis that occurs in up to 50% of cases. [1] [2] [3] Therapeutic penetrating keratoplasty (TPK) may be performed during a period of acute infection because of a patient's lack of response to medical therapy or for tectonic support. The graft survival for these transplantations is inferior when compared with transplantations that are performed for optical indications, and complications are common. 4, 5 The Mycotic Ulcer Treatment
Trial II (MUTT II) was a randomized clinical trial that found no benefit of adjuvant oral voriconazole in reducing the risk of perforation and/or TPK in severe filamentous fungal keratitis except for Fusiarum species ulcers. 3, 6 In this study, we investigate baseline demographic and clinical features in MUTT II that predict the eventuation to perforation and/or TPK. Identifying high-risk patients early may be useful to appropriately allocate resources in resource-poor settings.
Methods
The methods for MUTT II have been previously outlined. 7 Briefly, patients who presented with a smear-positive filamentous fungal corneal ulcer and a visual acuity worse than 20/400 (logMAR 1.3) were randomized to receive oral voriconazole or a placebo. All patients received topical voriconazole, 1%, and after the results of MUTT I became available, topical natamycin, 5%, was also administered to all patients. Enrollment centers included hospitals in the Aravind Eye Care System (Madurai, Pondicherry, Tirunelveli, or Coimbatore, India), Lumbini Eye Hospital and Bharatpur Eye Hospital in Nepal, and the University of California-San Francisco. Exclusion criteria included coinfection with bacteria, Acanthamoeba or herpes, an impending perforation, being younger than 16 years, poor visual acuity in the other eye (<20/200), a weight less than 40 kg, or known liver disease or pregnancy. The primary outcome of the trial was the rate of perforation and/or the need for TPK. Institutional review board approval was obtained at the University of California-San Francisco, the Aravind Eye Care System, the Dartmouth-Hitchcock Medical Center Committee for the Protection of Human Subjects, and Nepal Netra Jyoti Sangh. The trial conformed to the Declaration of Helsinki and written informed consent was obtained from all participants.
In this post hoc secondary analysis, we first assessed associations between baseline patient and ulcer characteristics and risk for the patient developing perforation and/or needing TPK in univariate logistic regression models. Statistically significant predictors (P < .05) were included in a subsequent multivariable model. Multivariable model selection was determined using a backward-stepwise regression with a cutoff P value of less than .20 for covariates. All analyses were conducted from March 1, 2017, to March 10, 2017, using Stata, version 13.0 (Stata Corp).
Results
A total of 240 patients were enrolled in Southeast Asia between May 24, 2010, and November 23, 2015, and 122 (50.8%) developed a full-thickness corneal perforation or needed to undergo TPK. Univariate analyses comparing baseline characteristics of those who developed perforation and/or required TPK compared with those who did not are outlined in Table 1 .
Results of the final multivariable model are listed in Table 2 . The presence of hypopyon at baseline indicated 2.28 times the odds of the patient developing a corneal perforation and/or needing TPK (95% CI, 1.18-4.40; P = .01). Infiltrate depth was graded as (1) no infiltrate, (2) infiltrate involving the anterior one-third of the stroma, (3) infiltrate involving up to two-thirds of the stroma, and (4) infiltrate involving the deepest third of the cornea. For each step increase in the infiltrate depth as measured at baseline there was 1.69 times the odds of the patient developing a fullthickness corneal perforation and/or needing TPK (95% CI, 1.12-2.53; P = .01). Study participants whose infiltrate involved the posterior third of the stroma had a 71.4% risk of developing a corneal perforation and/or needing TPK.
The infiltrate size was measured by taking the geometric mean of the longest diameter and longest perpendicular to that diameter in millimeters. The median baseline infiltrate size was 5.37 mm (interquartile range, 4.47-6.64). For each 1-mm increase in the geometric mean of the infiltrate there was 1.37 (95% CI, 1.12-1.67; P = .002) increased odds of the patient developing perforation and/or needing TPK. Study participants with a baseline infiltrate size more than a geometric mean of 6.63 mm (the highest quartile seen in MUTT II) had a 66.7% risk of developing perforation and/or needing TPK.
Baseline visual acuity was generally poor, with a median of logMAR 1.7 (interquartile range, 1.42-1.8). For each 1-line increase (worse) in baseline visual acuity, there was 1.06 times the odds of the patient developing perforation, although this was not statistically significant (95% CI, 0.81-4.65; P = .14). An agricultural occupation was no longer significantly protective in the multivariable analysis (odds ratio, 0.59; 95% CI, 0.33-1.08; P = .09). The Figure shows Kaplan-Meier survival curves comparing time with perforation and/or TPK among those with high-risk baseline ulcer features, defined as an infiltrate geometric mean size of more than 6.63 mm, an infiltrate involving the posterior one-third of the stroma, and the presence of a hypopyon compared with all other study participants.
Key Points
Question Do baseline clinical features predict the risk of developing corneal perforation and/or undergoing therapeutic penetrating keratoplasty in infectious keratitis?
Findings In this post hoc analysis of patients in the Mycotic Ulcer Treatment Trial II, we found that a baseline presence of hypopyon and infiltrate depth and size were statistically significant predictors of corneal perforation and/or the need for therapeutic penetrating keratoplasty.
Meaning Identifying patients who are at high risk of experiencing a poor outcome may be useful to allocate resources, particularly in resource-poor settings.
Discussion
This study suggests that stratification of severe fungal corneal ulcers based on clinical examination at baseline can select patients who are at the highest risk of experiencing a poor outcome. In our multivariable model, baseline infiltrate size and depth, as well as the presence of hypopyon, were the most associated with a patient developing corneal perforation and/or needing TPK. Other clinical features, such as visual acuity, epithelial defect size, baseline culture positivity, type of filamentous fungal organism, and duration of symptoms, were not statistically significant predictors in our study population. Demographics such as age, sex, and occupation were also not significant risk factors.
Therapeutic penetrating keratoplasty for fungal keratitis has been associated with worse vision-related quality of life; however, risk factors for the development of this complication have not been well characterized. 8 One retrospective case-control study of microbial keratitis of all types found several characteristics that predicted poor outcomes in univariate analyses, including older age, delay in referral, steroid use, poor vision, positive microbiology, fungal infection, large ulcer size, central location, the presence of hypopyon, prior perforation or descemetocele, and limbal involvement. 9 Another study that looked at pathology and the culture of TPK buttons found that deeper infiltrates, a heavy fungal load, and Fusarium species were risk factors for a patient developing a perforation. 10 A prospective study of less severe filamentous fungal ulcers found that only baseline epithelial defect size was a statistically significant predictor of perforation in multivariable analysis. 7 It has been well established that outcomes of therapeutic grafts fare worse than those for optical indications. 4, 11 The optimal timing of TPK is unknown, and some have argued that eliminating the infection surgically early could potentially improve clinical outcomes. [12] [13] [14] This could be an important area of future research if those at highest risk of requiring surgery could be identified early.
Strength and Limitations
The robust prospective data collection in several smear positive filamentous fungal ulcers is a strength of this study. Limitations include the fact that all study participants were enrolled in Southeast Asia; therefore, it is possible that organisms in this area exhibit different characteristics than those in other regions. Most infections were related to agricultural exposure and not contact lenses, as seen in most developed countries.
Conclusions
Risk stratification from baseline characteristics of large, severe fungal ulcers can identify those who are at highest risk of developing a corneal perforation and/or needing TPK. This is useful to allocate resources toward high-risk patients, particularly in resource-poor settings. Low-risk features
High-risk features
High-risk is defined as an infiltrate geometric mean size of more than 6.63 mm, an infiltrate involving the posterior one-third of the stroma, and a hypopyon.
Low-risk includes all other patients in the Mycotic Ulcer Treatment Trial II.
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